Literature DB >> 22539287

Ambivalent effects of dendritic cells displaying prostaglandin E2-induced indoleamine 2,3-dioxygenase.

Margit Lanzinger1, Birgit Jürgens, Ursula Hainz, Barbara Dillinger, Julia Raberger, Dietmar Fuchs, Andreas Heitger.   

Abstract

Prostaglandin E2 (PGE(2)), an abundantly produced lipid messenger in mammalian organisms, has been attributed to possess potent albeit ambivalent immunological functions. Recently, PGE(2) has been reported to stimulate the commonly believed immunosuppressive indoleamine 2,3-dioxygenase (IDO) pathway in human dendritic cells (DCs), but without promoting DC immunosuppressive activity. Here, we report that PGE(2) used as a DC maturation agent apparently has more diverse functions. PGE(2)-matured DCs acquired powerful IDO activity, which was sustained even after removing PGE(2). These IDO-competent DCs were able to stimulate allogeneic T-cell proliferation, but achieved inhibitory activity as their content in DC/T-cell co-cultures increased. The DC inhibitory activity was reversed upon blockade of IDO activity, confirming that the suppressive effect was in fact mediated by IDO and occurred in a dose-dependent fashion. IDO-mediated T-cell suppression was restored upon re-stimulation of T cells in the absence of IDO activity, confirming its reversibility. T cells stimulated by PGE(2)-matured IDO-competent DCs were sensitized to produce multiple cytokines, comprising Th1, Th2, and Th17 phenotypes. Collectively, these data suggest that T cells stimulated by PGE(2)-matured DCs are not terminally differentiated and their ultimate type of response may be formed by microenvironmental conditions.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22539287     DOI: 10.1002/eji.201141765

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

1.  IFN-γ and tumor gangliosides: Implications for the tumor microenvironment.

Authors:  Barbara Dillinger; Sarah Ahmadi-Erber; Manuel Lau; Markus A Hoelzl; Friedrich Erhart; Birgit Juergens; Dietmar Fuchs; Andreas Heitger; Stephan Ladisch; Alexander M Dohnal
Journal:  Cell Immunol       Date:  2018-02-02       Impact factor: 4.868

2.  Immunosuppressive mechanisms of regulatory dendritic cells in cancer.

Authors:  Galina V Shurin; Yang Ma; Michael R Shurin
Journal:  Cancer Microenviron       Date:  2013-06-09

3.  Indolamine 2,3-dioxygenase expression by monocytes and dendritic cell populations in hepatitis C patients.

Authors:  S Schulz; A Landi; R Garg; J A Wilson; S van Drunen Littel-van den Hurk
Journal:  Clin Exp Immunol       Date:  2015-06       Impact factor: 4.330

Review 4.  The role of indoleamine 2,3-dioxygenase in allergic disorders.

Authors:  Seyed-Alireza Esmaeili; Jafar Hajavi
Journal:  Mol Biol Rep       Date:  2022-01-14       Impact factor: 2.316

5.  CTLA4-Ig immunosuppressive activity at the level of dendritic cell/T cell crosstalk.

Authors:  Edda Mayer; Markus Hölzl; Sarah Ahmadi; Barbara Dillinger; Nina Pilat; Dietmar Fuchs; Thomas Wekerle; Andreas Heitger
Journal:  Int Immunopharmacol       Date:  2013-02-20       Impact factor: 4.932

6.  Indoleamine 2,3-dioxygenase controls fungal loads and immunity in Paracoccidioidomicosis but is more important to susceptible than resistant hosts.

Authors:  Eliseu F Araújo; Flávio V Loures; Silvia B Bazan; Claudia Feriotti; Adriana Pina; Alessandra S Schanoski; Tânia A Costa; Vera L G Calich
Journal:  PLoS Negl Trop Dis       Date:  2014-11-20

Review 7.  Cancer Immunotherapy by Targeting IDO1/TDO and Their Downstream Effectors.

Authors:  Michael Platten; Nikolaus von Knebel Doeberitz; Iris Oezen; Wolfgang Wick; Katharina Ochs
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

8.  Hepatic carcinoma-associated fibroblasts induce IDO-producing regulatory dendritic cells through IL-6-mediated STAT3 activation.

Authors:  J-T Cheng; Y-N Deng; H-M Yi; G-Y Wang; B-S Fu; W-J Chen; W Liu; Y Tai; Y-W Peng; Q Zhang
Journal:  Oncogenesis       Date:  2016-02-22       Impact factor: 7.485

9.  Vascular endothelial growth factor-A enhances indoleamine 2,3-dioxygenase expression by dendritic cells and subsequently impacts lymphocyte proliferation.

Authors:  Luciana Cavalheiro Marti; Lorena Pavon; Patricia Severino; Tatiana Sibov; Daiane Guilhen; Carlos Alberto Moreira-Filho
Journal:  Mem Inst Oswaldo Cruz       Date:  2013-10-09       Impact factor: 2.743

10.  Lactobacillus rhamnosus GG Activation of Dendritic Cells and Neutrophils Depends on the Dose and Time of Exposure.

Authors:  Shirong Cai; Matheswaran Kandasamy; Juwita N Rahmat; Sin Mun Tham; Boon Huat Bay; Yuan Kun Lee; Ratha Mahendran
Journal:  J Immunol Res       Date:  2016-07-20       Impact factor: 4.818

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.